Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: 5 cm colon-J-pouchProcedure: side-to-end anastomosisProcedure: straight coloanal anastomosis
- Registration Number
- NCT00238381
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Brief Summary
RATIONALE: Rectal reconstruction after surgery to treat rectal cancer may help patients keep some of their bowel function. It is not yet known which method of rectal reconstruction is most effective after surgery.
PURPOSE: This randomized phase III trial is studying three different methods of rectal reconstruction to compare how well they work in treating patients who are undergoing surgery for rectal cancer.
- Detailed Description
This is a randomized, multicenter study. Patients are stratified according to participating center, gender, distance of the distal tumor margin from the dentate line (\> 5 cm vs β€ 5 cm), age (\< 70 vs β₯ 70), neoadjuvant chemoradiotherapy (yes vs no), and distant metastasis (M0 vs M1). Patients are randomized to 1 of 3 treatment arms.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 336
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm II 5 cm colon-J-pouch Patients undergo TME and colon-J-pouch anastomosis rectal reconstruction. Arm I side-to-end anastomosis Patients undergo total mesorectal excision (TME) by standard methods or laparoscopically and side-to-end anastomosis rectal reconstruction. Arm III straight coloanal anastomosis Patients undergo straight coloanal anastomosis with/without temporary protective ileostomy
- Primary Outcome Measures
Name Time Method Composite evacuation score after total mesorectal excision 12 months after surgery
- Secondary Outcome Measures
Name Time Method Composite incontinence score after total mesorectal excision 6, 12, 18 and 24 months Morbidity 2 years follow-up Quality of life after total mesorectal excision 6, 12m 18 and 24 months Composite evacuation score at 6, 18, and 24 months after total mesorectal excision 6, 18 and 24 months after surgery Overall survival 2 years follow-up
Trial Locations
- Locations (18)
Kantonsspital Aarau
π¨πAarau, Switzerland
Kreiskrankenhaus LΓΆrrach
π©πͺLΓΆrrach, Germany
Inselspital Bern
π¨πBern, Switzerland
Hopital de La Chaux-de-Fonds
π¨πLa Chaux-de-Fonds, Switzerland
Hopitaux Universitaires de Geneve
π¨πGeneva, Switzerland
Kantonsspital Bruderholz
π¨πBruderholz, Switzerland
Ospedale Beata Vergine
π¨πMendrisio, Switzerland
Zuger Kantonsspital AG
π¨πBaar, Switzerland
Bezirksspital Dornach
π¨πDornach, Switzerland
Kantonsspital Winterthur
π¨πWinterthur, Switzerland
Klinik Hirslanden
π¨πZurich, Switzerland
Universitaetsspital-Basel
π¨πBasel, Switzerland
Centre Hospitalier Universitaire Vaudois
π¨πLausanne, Switzerland
Kantonsspital Luzern
π¨πLuzerne, Switzerland
UniversitaetsSpital Zuerich
π¨πZurich, Switzerland
Kantonsspital Olten
π¨πOlten, Switzerland
GZO Spital Wetzikon
π¨πWetzikon, Switzerland
City Hospital Triemli
π¨πZurich, Switzerland